E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/28/2016 in the Prospect News Convertibles Daily.

New Issue: Mainstreet Health prices $45 million bought deal of 5% convertible debentures due 2022

By Stephanie N. Rotondo

Seattle, Nov. 28 – Mainstreet Health Investments Inc. is offering $45 million of 5% convertible unsecured subordinated debentures due Jan. 31, 2022 via a bought deal led by National Bank Financial Inc., BMO Capital Markets and CIBC Capital Markets.

The financing was announced in tandem with the announcement of the acquisition of three memory care communities.

There is a $6.75 million over-allotment option.

The debentures are convertible into common stock at $11.00 per share. That represents a 15.8% premium over the Nov. 28 closing share price.

The company has the option to redeem the securities on or after Jan. 31, 2020 and prior to Jan. 31, 2021, if the stock price hits a 125% price hurdle. The paper can be redeemed at any time for any reason after Jan. 31, 2021.

Proceeds will be used to finance a portion of the purchase price of the memory care center acquisitions and for general corporate purposes.

Mainstreet Health is a Toronto-based health care real estate company.

Issuer:Mainstreet Health Investments Inc.
Securities:Convertible unsecured subordinated debentures
Amount:$45 million
Greenshoe:$6.75 million
Maturity:Jan. 31, 2022
Bookrunners:National Bank Financial Inc., BMO Capital Markets, CIBC Capital Markets
Coupon:5%
Price:Par of $1,000
Yield:5%
Call options:The company has the option to redeem the securities on or after Jan. 31, 2020 and prior to Jan. 31, 2021, if the stock price hits a 125% price hurdle. The paper can be redeemed at any time for any reason after Jan. 31, 2021
Conversion premium:15.8%
Conversion price:$11.00 per share
Pricing date:Nov. 28
Settlement date:Dec. 16
Stock listing:TSX: HLP-U
Stock price:$9.50 as of Nov. 28
Market capitalization:$306.08 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.